PTC Therapeutics, Inc. (PTCT) Financials
Key financial figures for PTC Therapeutics, Inc. (Q2 2026).
- Revenue
- $361M
- Net Income
- $83M
- EPS
- $1.01
- Total Assets
- $3.3B
- Operating Cash Flow
- $129M
Full income statement, balance sheet, and cash flow for PTC Therapeutics, Inc. on SentiSense.